PRCT Stock Analysis: Buy, Sell, or Hold?
PRCT - PROCEPT BioRobotics Corporation Common Stock
$20.60
-0.46 (-2.18%)
▼
5d:
-11.28%
30d:
-28.79%
90d:
-20.83%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Smart Money Accumulation
None View Scanner →
Strength: 6.6/10
Get Alerted When PRCT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PRCT is down 11.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PRCT is down 11.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PRCT is currently trading at $20.60, which is considered oversold relative to its 30-day fair value range of $23.38 to $28.66.
Technical Outlook: Technically, PRCT is in a downtrend. Immediate support is located at $19.92, while resistance sits at $29.74.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.22 (+46.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRCT is in a downtrend. Immediate support is located at $19.92, while resistance sits at $29.74.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.22 (+46.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$23.38 -
$28.66
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.7% below Wall St target ($30.22)
- WARNING: Recommendation downgraded due to -11.3% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$23.38 -
$28.66
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$19.92
Resistance Level
$29.74
Current Trend
Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-23.79
Wall Street Target
$30.22
(+46.7%)
Revenue Growth (YoY)
20.2%
Profit Margin
-31.8%
Share & Embed Analysis
Last updated: June 24, 2026 3:22 AM ET
Data refreshes hourly during market hours. Next update: 4:22 AM
Data refreshes hourly during market hours. Next update: 4:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRCT showing a specific setup today?
Insider Activity (6 Months)
3
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Alaleh Nouri
SELL
5363 shares
2026-03-19
Alaleh Nouri
SELL
304 shares
2026-03-17
Kevin Waters
SELL
706 shares
2026-03-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
